Skip to content

A study in overweight and pre-obese participants to compare the effects of interventional drug basil seeds and chia seeds on weight reduction.

A Randomized comparative clinical trial to evaluate the efficacy of basil seeds Barbari-Ocimum basilicum Linn. and Chia seeds-Salvia hispanica Linn. in the management of sthoulya w.s.r. to overweight/pre-obese. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098362
Enrollment
60
Registered
2025-12-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E889- Metabolic disorder, unspecified

Interventions

None listed

Sponsors

National Institute of Ayurveda,Deemed to be University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age: Participants aged between 18 and 60 years. 2.Overweight Status: Individuals with a BMI (Body Mass Index) ranging from 23 to 29.9 kg/m , indicating overweight and preobese status. 3.Health Status: Apparently healthy individuals without any significant medical conditions requiring medication. 4.Weight Stability: Individuals with stable body weight ( 2 kg) for at least three months before the study initiation. 5.Willingness to Comply: Participants willing to adhere to follow intervention for the entire study duration. 6.Ability to Give Consent: Individuals capable of providing informed consent for participation in the study.

Exclusion criteria

Exclusion criteria: 1.Medical Conditions: Participants with known history of significant uncontrolled medical conditions requiring medications such as Heart disease, Hypertension, Renal disorders, endocrine disorders, diabetes mellitus, neurological disorder etc. 2. Allergies or Intolerances: Participants with known allergies of the trial drug. 3. Pregnancy and Lactation: Pregnant or lactating individuals, as the dietary intervention may not be suitable during these periods. 4. Participation in Other Studies: Participants currently enrolled in other clinical studies or interventions related to weight management or nutrition. 5. Medication Use: Individuals taking medications or supplements known to affect weight or metabolic parameters. 6.Mental Health Concerns: Individuals with significant mental health conditions or eating disorders that could affect dietary adherence.

Design outcomes

Primary

MeasureTime frame
The primary outcome of the study is the change in body weight. This outcome will assess the effectiveness of basil seeds and chia seeds in promoting weight reduction in participants with sthoulya (overweight/pre-obese). Timepoint: Reduction of weight at the end of 2 month.

Secondary

MeasureTime frame
1. Changes in Subjective symptoms (lakshan of sthoulya) 2. Changes in BMI, weight measured in kilograms (kg) and the change in BMI, calculated as weight (kg) divided by height squared (m^2) after the dietary intervention. 3.Changes in Lipid profile (in subjects having dyslipidemia before study): (Total cholesterol, LDLcholesterol, HDL cholesterol, triglycerides). 4.Safety and Adverse Events: The occurrence of any adverse events, side effects, or safety concerns related to the dietary intervention will be recorded as secondary outcomes to ensure the intervention s safety profile. Timepoint: Improvement of Lipid profile at the end of 2 month.

Countries

India

Contacts

Public ContactDr Sumit Nathani

National Institute of Ayurveda, Deemed to be University

sumitnathani24@gmail.com7665809886

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026